Bronchodilatory Effect of the PPAR-gamma Agonist Rosiglitazone in Smokers With Asthma

Spears, M. et al. (2009) Bronchodilatory Effect of the PPAR-gamma Agonist Rosiglitazone in Smokers With Asthma. Clinical Pharmacology and Therapeutics, 86(1), pp. 49-53. (doi: 10.1038/clpt.2009.41)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Spears, Dr Mark and Thomson, Professor Neil and Chaudhuri, Dr Rekha and Brannigan, Mrs Maureen and Jolly, Miss Lisa and Lafferty, Mrs Jane and Donnelly, Mrs Iona and McSharry, Dr Charles
Authors: Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C., Lafferty, J., Chaudhuri, R., Braganza, G., Bareille, P., Sweeney, L., Adcock, I., Barnes, P., Wood, S., and Thomson, N.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Clinical Pharmacology and Therapeutics
ISSN:0009-9236

University Staff: Request a correction | Enlighten Editors: Update this record